Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Possible Benefits of Exogenous Melatonin for Individuals on Dialysis: A Narrative Review on Potential Mechanisms and Clinical Implications Publisher Pubmed



Movahhed SMM1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Baharloo Hospital, Tehran University of Medical Sciences, Tehran, Iran

Source: Naunyn-Schmiedeberg's Archives of Pharmacology Published:2021


Abstract

Prevention of oxidative stress and inflammation in chronic kidney disease patients (CKD) on dialysis may reduce dialysis-associated complications. Administration of powerful antioxidants may improve the consequences of peritoneal dialysis (PD) and hemodialysis (HD). This narrative review aimed to show the potential therapeutic effects of melatonin (MLT) on the consequences of CKD patients receiving HD or PD. The results of preclinical and clinical studies have proven that CKD and dialysis are accompanied by reduced endogenous MLT levels and related complications such as sleep disorders. Enhanced oxidative stress, inflammation, cellular damages, and renal fibrosis, along with dysregulation of the renin-angiotensin system (RAS), have been observed in CKD and patients on dialysis. Results of studies have revealed that the restoration of MLT via the exogenous source may regulate oxidative stress, inflammation, and RAS functions, inhibit fibrosis, and improve complications in patients with long-term dialysis patients. In summary, treatment of patients with CKD and dialysis with exogenous MLT is suggested as a practical approach in reducing the outcomes and improving the quality of life in patients via antioxidant, anti-inflammatory, and anti-fibrotic signaling pathways. Therefore, this hormone can be considered in clinical practice to manage dialysis-related complications. © 2021, The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Related Docs
View other Related Docs
1. The Effect of Melatonin on Cisplatin-Induced Nephrotoxicity: A Pilot, Randomized, Double-Blinded, Placebo-Controlled Clinical Trial, European Journal of Integrative Medicine (2020)
2. Melatonin As a Therapeutic Agent for the Inhibition of Hypoxia-Induced Tumor Progression: A Description of Possible Mechanisms Involved, International Journal of Molecular Sciences (2021)
3. Molecular Mechanisms of Melatonin in Alzheimer’S Disease: Insights From Network Pharmacology and Molecular Docking, Journal of Contemporary Medical Sciences (2025)
4. Mechanisms for Radioprotection by Melatonin; Can It Be Used As a Radiation Countermeasure?, Current Molecular Pharmacology (2019)
5. Effects of Melatonin Supplementation on Oxidative Stress: A Systematic Review and Meta-Analysis of Randomized Controlled Trials, Hormone Molecular Biology and Clinical Investigation (2020)
6. Night Shift Hormone: How Does Melatonin Affect Depression?, Physiology and Behavior (2022)
7. Effects of Melatonin Supplementation on Oxidative Stress, and Inflammatory Biomarkers in Diabetic Patients With Chronic Kidney Disease: A Double-Blind, Randomized Controlled Trial, BMC Nutrition (2025)
8. Effect of Melatonin Supplementation on Cardiometabolic Risk Factors, Oxidative Stress and Hormonal Profile in Pcos Patients: A Systematic Review and Meta-Analysis of Randomized Clinical Trials, Journal of Ovarian Research (2024)
Experts (# of related papers)
View all Related Experts
Monirsadat Hakemi (2)
Hossein Imani (2)
Other Related Docs
9. Effects of Melatonin Supplementation on Metabolic Parameters, Oxidative Stress, and Inflammatory Biomarkers in Diabetic Patients With Chronic Kidney Disease: Study Protocol for a Double-Blind, Randomized Controlled Trial, Trials (2024)
10. Effect of Melatonin Supplementation on Sleep Quality: A Systematic Review and Meta-Analysis of Randomized Controlled Trials, Journal of Neurology (2022)
11. Association Between Systemic Immune-Inflammation Index and Risk of Chronic Kidney Disease; a Systematic Review and Meta-Analysis, Journal of Nephropathology (2025)
12. Effects of Melatonin Supplementation on Hormonal, Inflammatory, Genetic, and Oxidative Stress Parameters in Women With Polycystic Ovary Syndrome, Frontiers in Endocrinology (2019)
13. Kidney Diseases and Covid-19 Infection: Causes and Effect, Supportive Therapeutics and Nutritional Perspectives, Heliyon (2021)
14. Associations of Body Composition, Muscle Function, and Physical Activity With Mortality in Peritoneal Dialysis Patients, Iranian Journal of Kidney Diseases (2020)
15. Melatonin and 5-Fluorouracil Combination Chemotherapy: Opportunities and Efficacy in Cancer Therapy, Cell Communication and Signaling (2023)
16. The Effect of Melatonin on Behavioral, Molecular, and Histopathological Changes in Cuprizone Model of Demyelination, Molecular Neurobiology (2016)
17. Melatonin Ameliorates Astrogliosis and Microgliosis in a Cuprizone Demyelinating Mouse Model, Biochemistry and Biophysics Reports (2025)
18. Association Between Melatonin Value and Interleukins-1B,-18, And-33 Levels in Patients With Different Stages of Non-Alcoholic Fatty Liver Disease, Middle East Journal of Digestive Diseases (2022)
19. Melatonin for Gastric Cancer Treatment: Where Do We Stand?, Naunyn-Schmiedeberg's Archives of Pharmacology (2025)
20. Evidence for the Benefits of Melatonin in Cardiovascular Disease, Frontiers in Cardiovascular Medicine (2022)
21. Melatonin and Cisplatin Co-Treatment Against Cancer: A Mechanistic Review of Their Synergistic Effects and Melatonin's Protective Actions, Pathology Research and Practice (2024)
22. Influence of Hormones in Multiple Sclerosis: Focus on the Most Important Hormones, Metabolic Brain Disease (2023)
23. Impact of Melatonin Supplementation on Glycemic Parameters in Patients With Type 2 Diabetes: A Systematic Review and Meta-Analysis, Current Pharmaceutical Design (2025)
24. The Effects of Melatonin Supplementation on Parameters of Mental Health, Glycemic Control, Markers of Cardiometabolic Risk, and Oxidative Stress in Diabetic Hemodialysis Patients: A Randomized, Double-Blind, Placebo-Controlled Trial, Journal of Renal Nutrition (2020)